Abstract:Although a clear mechanism underlying the pathophysiology of schizophrenia (SZ) remains elusive, oxidative stress, inflammatory syndrome and immune activation have become an attractive hypothesis for explaining the pathophysiology of SZ. Data from prior studies on the role of matrix metalloproteinase 9 (MMP-9) and brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms (SNPs) in SZ are contradictory. We aimed to investigate whether oxidative stress, inflammatory and immune activation markers as well as MMP-9 levels may be implicated in SZ pathogenesis. The association of MMP-9 and BDNF SNPs with the clinical expression of SZ was examined.Ninety-four subjects were recruited, including 44 SZ patients and 50 healthy controls. Serum levels of thiobarbituric acid reactive substances (TBARS), protein carbonyl content (PCC), nitrite, C-reactive protein (CRP), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), Beta-2 microglobulin (Β2M), complement component 3 (C3), C4 and MMP-9 were measured. The MMP-9 − 1562C > T and BDNF196G > A SNPs were genotyped using polymerase chain reaction-restriction fragment length polymorphism assay. Psychopathology was assessed using the positive and negative syndrome scale (PANSS).SZ patients showed significantly higher TBARS, PCC, nitrite, CRP, IL-6, TNF-α, Β2M, C3 and MMP-9 levels than controls. In distinguishing SZ patients from healthy controls, CRP and MMP-9 yielded similar discriminatory performance, and both perform better than IL-6, Β2M, C3, nitrite, TBARS, PCC, TNF-α and C4. The MMP-9 − 1562C > T SNP genotypes distribution didn't differ significantly between controls and SZ patients. As compared to controls, SZ patients harbor a significantly higher frequency of the BDNF196GG genotype and a lower frequency of the BDNF196GA/AA genotype. Patients carrying the MMP-9 − 1562CC or BDNF196GG genotype revealed a significantly higher PANSS than those carrying MMP-9 − 1562CT/TT or BDNF196GA/AA genotype. Male gender and the MMP-9 − 1562CC genotype were identified as independent predictive factors for higher PANSS.Redox dysregulation and alterations in the immuno-inflammatory pathways are major culprits in the pathogenesis of SZ. MMP-9 and BDNF SNPs are associated with the clinical phenotype of SZ and, thus, may be a useful marker predicting the phenotypic expression and prognosis of SZ patients.

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

DNA Methylation in Schizophrenia: Progress and Challenges

The C(−1562)T Polymorphism of Matrix Metalloproteinase-9 Gene is Associated with Schizophrenia in China

The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

DNA Hyper-methylation Associated with Schizophrenia May Lead to Increased Levels of Autoantibodies

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal study

DNA Methylation Meta-Analysis Reveals Cellular Alterations in Psychosis and Markers of Treatment-Resistant Schizophrenia

Methylomic Alteration in Peripheral Blood Lymphocytes of Prodromal Stage and First-Episode Chinese Han Schizophrenia Patients

The DNA Methylation Profile Within the 5′-Regulatory Region of DRD2 in Discordant Sib Pairs with Schizophrenia

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia

Hyper-Coordinated DNA Methylation is Altered in Schizophrenia and Associated with Brain Function

DNA hyper-methylation associated with schizophrenia may lead to breakdown of self-tolerance

Epigenetic profile of the immune system associated with symptom severity and treatment response in schizophrenia

An analysis of POMC gene methylation and expression in patients with schizophrenia

DNA Methylation Differences in Cortical Grey and White Matter in Schizophrenia.

Schizophrenia is associated with altered DNA methylation variance